Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Goodwill & Intangibles (2019 - 2025)

Historic Goodwill & Intangibles for Pulmonx (LUNG) over the last 7 years, with Q3 2025 value amounting to $2.3 million.

  • Pulmonx's Goodwill & Intangibles changed 0.0% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $2.3 million for FY2024, which is 131.13% down from last year.
  • Pulmonx's Goodwill & Intangibles amounted to $2.3 million in Q3 2025, which was down 0.0% from $2.3 million recorded in Q2 2025.
  • Over the past 5 years, Pulmonx's Goodwill & Intangibles peaked at $2.7 million during Q1 2021, and registered a low of $2.3 million during Q1 2024.
  • In the last 5 years, Pulmonx's Goodwill & Intangibles had a median value of $2.4 million in 2023 and averaged $2.5 million.
  • Its Goodwill & Intangibles has fluctuated over the past 5 years, first tumbled by 500.81% in 2024, then changed by 0.0% in 2025.
  • Pulmonx's Goodwill & Intangibles (Quarter) stood at $2.6 million in 2021, then dropped by 4.71% to $2.5 million in 2022, then dropped by 4.95% to $2.4 million in 2023, then dropped by 1.31% to $2.3 million in 2024, then changed by 0.0% to $2.3 million in 2025.
  • Its Goodwill & Intangibles stands at $2.3 million for Q3 2025, versus $2.3 million for Q2 2025 and $2.3 million for Q1 2025.